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It has been suggested that transglutaminase 1 is proteo-
lytically activated upon the terminal di¡erentiation of
the keratinocyte, but the mechanisms are not well un-
derstood. We have established two mouse hybridoma
cell lines producing monoclonal antibodies that speci¢-
cally detect proteolytically cleaved transglutaminase 1.
One detects the amino-terminus of the fragment pro-
duced by cleavage between Arginine 93 and Glycine 94,
and the other detects the amino-terminus of the frag-
ment produced by cleavage between Arginine 573 and
Glycine 574. Using these two antibodies, immunohisto-
chemical analyses of the epidermis revealed that the
cleavages of the transglutaminase 1 protein occur early
in the terminal di¡erentiation of keratinocytes in the
basal layer of the epidermis, that the cleavage between
Arginine 573 and Glycine 574 (producing the 574G frag-
ment) precedes the cleavage between Arginine 93 and
Glycine 94 (producing the 94G fragment), that the 94G
fragment is localized to the plasma membrane of kera-
tinocytes and has cross-linking activity, whereas the
574G fragment is dispersed in the cytosol and does not
have detectable levels of activity on in situ transglutami-
nase assay, and that 1-a-25-dihydroxycholecalciferol or
all-trans retinoic acid treatment and ultraviolet B expo-
sure disturb the localization of the transglutaminase 1
fragments with changes in the morphology of di¡eren-
tiating keratinocytes. All these results demonstrate that
the antibodies generated in this work are useful to dis-
sect the mechanism by which transglutaminase 1 is ac-
tivated, and would provide us with novel insights into
the biogenesis of the epidermis. Key words: antibodies/
cell di¡erentiation/epidermis/keratinocyte/transglutaminase 1. J
Invest Dermatol 121:457 ^464, 2003
T
ransglutaminases (TGase; EC 2.3.2.13) are calcium-
dependent enzymes that catalyze the formation of
covalent bonds between the glutamyl residues and
lysyl residues of either proteins or polyamines
(Greenberg et al, 1991). These reactions are observed
in cells and tissues from bacteria to vertebrates, and result in stable
bonds, resistant to chemical, enzymatic, and physical degradation
(Tokunaga et al, 1993; Cariello et al, 1997; Kobayashi et al, 1998;
Makarova et al, 1999).
Among several isotypes of TGase in mammals, TGase1 and
TGase3 are thought to contribute to maintain the toughened skin
epidermis through cross-linking activity (Greenberg et al, 1991).
During the terminal di¡erentiation of keratinocytes, some struc-
tural proteins are cross-linked byTGase1 and/or TGase3 to form a
corni¢ed envelope (CE) that acts as an important barrier against
water loss in the skin epidermis (Ya¡e et al, 1992; Candi et al, 1995).
Recently, it was reported (Nemes et al, 1999b) that TGase1 has the
ability to attach o-hydroxyceramide, an important lipid in the
formation of CE, to involucrin, one of the structural proteins in-
volved in CE formation (Ya¡e et al, 1992). The resultant protein^
lipid complexes probably improve the function of the CE in pre-
venting water loss. Loss of TGase1 activity in mice results in early
neonatal death at least partly due to the failure of CE formation
(Matsuki et al, 1998), suggesting that TGase3 activity cannot com-
pensate for the function of TGase1. Therefore,TGase1 is regarded
as one of the most important enzymes for the construction of the
CE (Thacher and Rice, 1985; Kuramoto et al, 2002).
TGase1 is synthesized as an 817-residue polypeptide and exists
as a membrane-anchored precursor protein modi¢ed by myris-
toyl or palmitoyl adducts near its amino-terminus in keratino-
cytes (Chakravarty and Rice, 1989; Steinert et al, 1996b). Upon
the terminal di¡erentiation of keratinocytes, TGase1 is cleaved at
two sites, which leads to a more active form (Rice et al, 1990; Kim
et al, 1995a; Steinert et al, 1996a; Candi et al, 1998). The cleavage
sites have been proved to be at the amino-terminal sides of glycyl
resides at position 94 (Glycine 94) and at position 574 (Glycine
574) (Kim et al, 1995a). It is hypothesized that cleavage at Glycine
574 plays a part in removing the hindrance of catalytic core do-
main in the precursor form (Candi et al, 1998), or in enhancing
the activity of active TGase1 fragment when they associate to-
gether (Kim et al, 1995a). The activation mechanisms are not well
understood, however, especially in vivo, due to few useful tools
with which the catalytic fragments of TGase1 can be detected di-
rectly in the epidermis.
We have successfully used cleavage site-directed antibodies in
the past for various bioactive molecules (Imajoh-Ohmi et al,
1992; Kikuchi and Imajoh-Ohmi, 1995; Kato et al, 2000; Niikura
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et al, 2002). Therefore, in our new attempt to clarify the mechan-
ism of activation and physiologic function of TGase1, we estab-
lished two hybridoma cell lines producing such antibodies. One
detects the amino-terminus of the fragment produced by clea-
vage at Glycine 94 (94G fragment), and the other detects the ami-
no-terminus of the fragment produced by cleavage at Glycine 574
(574G fragment). As shown in this study, these antibodies provide
us with novel tools to dissect the mechanism by which TGase1 is
activated during the terminal di¡erentiation of keratinocytes and
the fate of TGase1-derived fragments in the construction of the
epidermis. All experiments were performed with the approval of
the Ethical Committee for HumanTissue Experiments of the Ya-
kult Central Institute, and animals were handled according to the
guidelines of the Ethical Committee for Animal Experiments of
Yakult Central Institute.
MATERIALS AND METHODS
Establishment of hybridoma cell lines producing monoclonal
antibodies Peptides corresponding to the amino-terminus of a frag-
ment generated by cleavage at Glycine 94 (GSGVNAAGDGTIREG, Pep2)
and its preprocessed form (CSDSRRPVSRGSGVNAAGDGTIREG,
Pep1), or to the amino-terminus of a fragment generated by cleavage
at Glycine 574 (GSAEDVAMQVEA, Pep4) and its preprocessed form
(CSKPNVYANRGSAEDVAMQVEA, Pep3), were synthesized on a
Shimadzu PSSM-8 peptide synthesizer according to the Fmoc method,
and protecting groups and linkers were cleaved by treatment with
tri£uoroacetic acid. The peptides were then conjugated to a carrier protein
(keyhole limpet hemocyanin) as previously described (Imajoh-Ohmi et al,
1992).
Female BALB/C mice were injected subdermally with 100 mg of the
synthetic peptide (Pep2 or Pep4) emulsi¢ed with Freund’s complete
adjuvant (DIFCO, Detroit, Michigan) on day 1. Five additional
immunizations with 100 mg of peptide were made intraperitoneally with
Freund’s incomplete adjuvant (DIFCO) at 2 wk intervals. The ¢nal
injection of 100 mg of peptide in saline was made intravenously without
adjuvant 5 d prior to being euthanized.
Spleen cells from the immunized mice were fused with mouse myeloma
P3-NS-1/a-Ag4-1 cells (Mike et al, 1994), and the standard hybridoma
technique was adopted. Brie£y, after incubation for 5 min at 371C in
polyethylene glycol 6000 (Wako, Osako, Japan) containing 45% RPMI
1640 (Sigma, St. Louis Missouri), fused cells were grown in a selection
medium consisting of RPMI1640 supplemented with 15% (v/v) fetal
bovine serum (Dainippon Pharmaceutical, Osaka, Japan), 80 U per mL of
penicillin G, 80 mg streptomycin per mL (Life Technologies, Rockville,
Maryland), 0.1 mM hypoxamine, 0.4 mM aminopterin, and 0.016 mM
thymidine at 371C under a humidi¢ed atmosphere of 7% CO2. Fourteen
days after the fusion, cell supernatants were screened with an enzyme-
linked immunosorbent assay using the respective synthetic peptides as
immunogens. Cells giving positive signals were subcloned at least twice
by the limited dilution method, and the antibodies were isotyped using a
Mouse MonoAB ID/SP Kit (Zymed Laboratories, Inc., San Francisco,
California). The hybridoma clone R1410H, obtained with the Pep2,
produced IgG2a antibodies (anti-94G), whereas the hybridoma clone
M13E, obtained with the Pep4, produced IgG2b antibodies (anti-574G).
To obtain plenty of these monoclonal antibodies, hybridoma cells were
injected intraperitoneally into mice, and the ascites £uids gathered were
applied on protein G columns (Pharmacia Biotech, Uppsala, Sweden) to
purify the antibodies.
Enzyme-linked immunosorbent assay enzyme-linked immuno-
sorbent assay was carried out according to the method of Mike et al (1994)
with slight modi¢cation. Brie£y, each of the peptides (50 ng) was coated
on immuno-plates (MaxiSorp from Nunc, Roskilde, Denmark) as
immunogens. After blocking with bovine serum albumin fraction V
(BSA; Boehringer Mannheim, Germany), the plates were incubated at
room temperature for 1 h with puri¢ed antibodies at appropriate dilutions
(1:2000). Peroxidase-conjugated anti-mouse IgG (Jackson Immuno-
Research, West Grove, Pennsylvania) were added, and the plates were
incubated at room temperature for 1 h, followed by an enzymatic reaction
with the substrates for peroxidase (ImmunoPure TMB Substrate Kit;
Pierce, Rockford, Illinois) at room temperature for 30 min. The reaction
was terminated by the addition of 2 M sulfuric acid, and the absorbance
at 492 nm was determined (Bio Kinetics Reader from Bio-Tek,Winooski,
Vermont).
Preparation of monolayer-cultured keratinocyte Primary cultured
normal human epidermal keratinocytes (Epidercell NHEK(F) from
Kurabo Biomedical Business, Osaka, Japan) were seeded on tissue culture
dishes (Becton Dickinson, Franklin Lakes, New Jersey) or collagen-coated
cover glasses (Iwaki, Osaka, Japan) and grown at 371C (5% CO2,
humidi¢ed atmosphere) in keratinocyte growth medium supplemented
with 10 mg insulin per mL, 0.1 ng human epidermal growth factor per
mL, 0.5 mg hydrocortisone per mL, 0.4% (v/v) bovine pituitary extract,
50 mg gentamicin per mL, and 50 ng amphotericin B per mL (Humedia-
KG2; Kurabo Biomedical Business). For coercive di¡erentiation,
subcon£uent cells were challenged with 1mMCaCl2 and incubated for 48 h.
Western blot and immunoprecipitation analyses For western
blot analysis, 106 monolayer-cultured keratinocytes were harvested
and sonicated in phosphate-bu¡ered saline (pH 7.4) without CaCl2 and
MgCl2 (PBS) containing an excess of protease inhibitor cocktail
(Complete, Mini; Roche, Mannheim, Germany). After removing cellular
debris by centrifugation (16,000 g), the cell lysates were dissolved in
sodium dodecyl sulfate (SDS) sample bu¡er containing 2.3% (w/v) SDS,
10% (w/v) glycerol, 5% (v/v) 2-mercaptoethanol, and 10 mg bromophenol
blue per mL in 125 mMTris^HCl (pH 6.8), and heated to 1001C for 3 min.
These samples were subjected to SDS^polyacrylamide gel electrophoresis,
12% (w/v) acrylamide followed by electrical transfer on to a poly-
vinylidene £uoride membrane (Immobilon; Millipore, Billerica,
Massachusetts). The membrane was soaked in Tris-bu¡ered saline (pH 7.5)
containing 20 mg BSA per mL for 1 h at room temperature, and incubated
with anti-574G (1:1000 dilutions) for 2 h at room temperature. Then the
antibody-treated membrane was washed to remove the excess antibodies,
and incubated with anti-mouse IgG conjugated with alkaline phosphatase
(Promega, Madison, Wisconsin). Antigens were visualized by the
enzymatic reaction of alkaline phosphatase with 5-bromo-4-chloro-3-
indolylphosphate and nitro blue tetrazolium (Promega).
For immunoprecipitation analysis, 107 monolayer-cultured keratinocytes
were harvested. Immunoprecipitation with anti-94G (1:50 dilutions) was
performed by using IMMUNOcatcher system (CytoSignal, Irvine,
California). Pre-immune serum of normal BALB/C mouse was used to
remove the components, which nonspeci¢cally bind to antibodies.
Protein speci¢cally bound to anti-94G was subjected to SDS^
polyacrylamide gel electrophoresis (7.5% (w/v) acrylamide) and detected
by Coomassie brilliant blue staining.
Immuno£uorescence analysis Frozen sections of normal human skin
(BioChain Institute, Inc., Hayward, California), monolayer-cultured
keratinocytes on collagen-coated cover glasses, and frozen sections of
three-dimensional living skin equivalent (described below), were ¢xed
with acetone at ^201C, rinsed with PBS containing 0.1% (w/v) BSA, and
treated with 10% (v/v) normal horse serum (Boehringer Mannheim) to
block nonspeci¢c binding. Then the samples were incubated at room
temperature for 2 h with the antibodies (1:50 dilutions). To perform
epitope-competition experiments, antibodies were incubated with
respective immunogens or control peptide at 41C for 2 h before the
sample incubation. Excess antibodies were removed, and the samples
were again incubated at room temperature for 2 h with £uore-
scein isothiocyanate (FITC)-conjugated anti-mouse IgG (Jackson
ImmunoResearch). For some analyses, nuclei were stained with 10 mg
propidium iodide per mL. These samples were mounted with mounting
medium (Vectashield, Vector, Burlingame. California), and observed
under a Confocal Laser Imaging System (Bio-Rad, Hercules, California).
For the analysis of the epitope-competition experiments, FITC intensity
was measured using an image analyzer withWin ROOF software (Mitani
Corporation,Tokyo, Japan).
In situ TGase assays Frozen sections of normal human skin (BioChain
Institute, Hayward, CA) were rinsed with 1% (w/v) BSA in Tris-bu¡ered
saline, and incubated at 371C for 1 h with 500 mM 5-(Biotinamido)
pentylamine (5-BAP; Pierce, Rockford, Illinois) in Tris-bu¡ered saline
containing protease inhibitors (Complete, Mini, ethylenediamine
tetraacetic acid-free, Roche, Mannheim, Germany) with 5 mM CaCl2 or
with 5 mM ethylenediamine tetraacetic acid. The sections were ¢xed with
acetone at ^201C, rinsed with PBS, and treated with 10% (v/v) normal
horse serum to block nonspeci¢c binding. After incubation at room
temperature for 1 h with TRITC-conjugated streptavidin ( Jackson
ImmunoResearch), the sections were mounted with mounting medium
and observed with the Confocal Laser Imaging System (Bio-Rad).
Preparation of three-dimensional living skin equivalents (LSE)
Three-dimensional LSE (manufactured by Toyobo, Osaka, Japan) were
cultured at 371C (5% CO2, humidi¢ed atmosphere) in 1:1 HamF12/
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Dulbecco minimal Eagle’s medium containing 1% fetal bovine serum
(LSE assay medium; Toyobo) by the air^liquid interface method (Bell
et al, 1991). Some LSE were challenged with 510^7 M 1-a-25-dihydroxy-
cholecalciferol (Solvay Pharmaceuticals, Weesp, the Netherlands) or 5
 10^7 M all-trans retinoic acid (RA; Sigma) via the liquid phase (culture
medium) at 2 wk after the beginning of the air^liquid interface culture,
and then incubated for 4 d at 371C. Other LSE were exposed to 25 mJ
per cm2 per day of ultraviolet B (VL-115 from Vilber Lourmat, Cedek,
France; Ultraviolet spectral curve was measured by Spectroradiometer SS-
11 from Maki Manufacturing Co. Ltd, Tokyo, Japan) via the air phase
(stratum corneum equivalent of LSE) for 3 d, 2 wk after the beginning of
the air^liquid interface culture. Immuno£uorescence analyses of frozen
sections of these LSE were performed similarly to those of normal human
skin.
RESULTS
Preparation and speci¢cities of cleavage site-directed
antibodies for cleaved TGase1 We established two di¡erent
hybridoma cell lines that produced antibodies against synthetic
peptides corresponding to the two cleavage sites (Figs 1 and 2A).
In enzyme-linked immunosorbent assay, the antibody raised
against Pep2 (anti-94G) exclusively bound to Pep2, and not to
Pep1, 3, or 4 (Fig 2B). Similarly, the antibody raised against
Pep4 (anti-574G) predominantly bound to Pep4, with much less
binding to Pep1, 2, and 3 (Fig 2C).
In immuno£uorescence analyses, these antibodies were
successfully used to stain human epidermal sections as well as
cultured human keratinocytes as described below (see Figs 3^5).
We performed competitive inhibition experiments using these
antibodies and synthetic peptides in these analyses. As shown in
Fig 2(D,E) the immuno£uorescence stainings with anti-94G and
anti-574G were clearly inhibited by prior incubation of the
antibodies with Pep2 and Pep4, respectively, but not with the
corresponding precursor peptides (Pep1 and Pep3).
In order to detect the binding of these antibodies to cellular
TGase1-derived fragments, we performed western blot analysis
of monolayer-cultured keratinocyte lysates. Anti-574G detected
33 kDa protein in the cytosol fraction of the cell. Furthermore,
the intensity of the protein band increased as cell di¡erentiation
was induced with Ca2þ (Fig 2F). On the other hand, we could
not detect any speci¢c protein band with anti-94G in the same
western blot analysis (data not shown). From the consideration
that the preparation method for western blot would severely
reduce the antigenic property of the antigen of anti-94G,
immunoprecipitation assay was performed. Consequently, anti-
94G speci¢cally bound to 67 kDa protein in coercively
di¡erentiated keratinocyte lysates (Fig 2G).
Immunohistochemical analysis of normal human skin
epidermis Figure 3 shows immuno£uorescence microscopy
of a typical sample of human skin stained with each of the
monoclonal antibodies. Most of the epidermal layers were
stained with both anti-94G and anti-574G. When looking into
the stained regions in more detail, however, there are substantial
di¡erences in the staining patterns between them. Anti-574G
stained the entire epidermis, especially the basement membrane
and stratum corneum, whereas the regions stained with anti-
94G included the suprabasal layer, spinous layer, and granular
layer, but not the basement membrane or stratum corneum. In
addition, the anti-94G-positive regions were limited to the
periphery of each keratinocyte, whereas anti-574G stained the
cytosolic regions of the cells. Hair follicles were also stained by
both anti-574G and anti-94G.
Similar staining patterns were observed in 16 normal human
skin samples (data not shown).
TGase cross-linking activity in epidermis We measured the
cross-linking activity of TGase in epidermis by detecting 5-BAP
(Lee et al, 1988) incorporation as described in Materials and
Methods. Consequently, 5-BAP was incorporated into the entire
epidermis (Fig 6A). As 5-BAP is not a speci¢c substrate for
TGase1, there is a possibility that we also detected the activity of
TGase3 in the granular layer, with the result that a much greater
extent of incorporation in the granular layer than in the other
layers was detected; however, because pH 7.4 assay conditions in
our experiments are more suitable for the detection of activity
derived from TGase1 than from TGase3 (Raghunath et al, 1998),
and as no other TGase isotype has been described in the region,
the activity detected in the basal and spinous layers cells is
probably derived from TGase1. The 5-BAP incorporated into
the region was localized to the periphery of the keratinocytes
(Fig 6B), which coincided with the localization pattern of the
antigen detected by anti-94G (Fig 3B). In the absence of Ca2þ ,
5-BAP was not incorporated into the epidermis (Fig 6C).
Detection of TGase1 fragments in monolayer-cultured
keratinocytes At low Ca2þ concentrations in the culture
medium (0.03^0.3 mM), primary cultured keratinocytes grow
as a monolayer with a high rate of proliferation until they be-
come con£uent. Postcon£uently cultured cells di¡erentiate
spontaneously even at low Ca2þ concentrations (Dlugosz and
Yuspa, 1994); when the Ca2þ concentration in the medium is
raised to 1.8 mM, cell di¡erentiation is induced more coercively,
resulting in the expression of many di¡erentiation markers,
including TGase1 (Hennings et al, 1989; Dlugosz and Yuspa, 1994;
Gibson et al, 1996).We employed these cultured cells to investigate
the relationship between cell di¡erentiation and the cleavage of
TGase1.
Normal human primary keratinocytes were seeded and grown
in the growth medium (0.3 mM CaCl2) until they became
con£uent. Aliquots of the cells were cultured postcon£uently to
induce di¡erentiation spontaneously, or treated with 1mMCaCl2
to induce di¡erentiation coercively.
The anti-574G stained both highly proliferating cells (Fig 4A)
and con£uent cells (Fig 4B). The staining was detected mostly in
the cytosol, and was enhanced in di¡erentiating cells (Figs 2F
and 4C,D).
In contrast to the results with anti-574G, the anti-94G antibody
stained only di¡erentiating cells (Figs 2G and 4G,H), rather than
Figure1. Cleavages of TGase1 and cleavage site-directed antibodies.
The carboxyl-terminus of TGase1 is anchored to the plasma membrane.
The meshed portion indicates the catalytic region for TGase cross-linking
activity. The intact TGase1 is cleaved (Cleavages) between arginine 93
(93R) and glycine 94 (94G), or between arginine 573 (573R) and glycine
574 (574G), and catalytic fragments are produced. Cleavage site-directed
antibodies (anti-94G, anti-574G) detect a positive charge (þ ) in the ami-
no-terminus (94G, 574G) of the newly produced catalytic fragments.
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the proliferating (Fig 4E) or con£uent cells (Fig 4F). The
staining was detected mostly in the cell periphery.
Immuno£uorescence analysis of three-dimensionally di¡eren-
tiating cells When normal primary keratinocytes are
cultured by the air^liquid interface method on collagen lattices
containing dermal ¢broblasts, they di¡erentiate three-
dimensionally until a stratum corneum-like structure is formed
(Bell et al, 1991). This three-dimensional culture, termed LSE,
shows a high degree of similarity to normal human epidermis
in morphologic and biochemical characteristics (Bilbo et al, 1993;
Nolte et al, 1993).
When a normally cultured LSE was stained with either anti-
94G or anti-574G, the staining pattern was quite similar to that
of normal human epidermis (Fig 5A,E). Addition of 1-a-25-
dihydroxycholecalciferol (VD) to the culture medium slightly
increased the intensity of staining by both anti-94G and anti-
574G. The epidermis equivalent was slightly hyperplastic (Fig
5B,F). Addition of RA to the culture medium decreased the
intensity of staining with anti-94G, especially at the periphery
of keratinocytes in the basal layer equivalent, whereas staining
with anti-574G seemed not to be signi¢cantly a¡ected. The cells
became squamous (Fig 5C,G). Exposure to ultraviolet B clearly
reduced the intensity of staining not only by anti-94G but also
Figure 2. Speci¢city of Anti-94G and Anti-574G. Synthetic peptides mimicking the amino-terminus of each catalytic fragment (Pep2, Pep4) were used
as immunogens in the preparation of anti-94G and anti-574G. Pep1 and Pep3 indicate synthetic peptides mimicking the uncleaved forms (A). Anti-94G was
predominantly adsorbed by Pep2 (B), whereas anti-574G was predominantly adsorbed by Pep4 (C) on an enzyme-linked immunosorbent assay. Anti-94G
was adsorbed by Pep2 rather than Pep1 on immunohistochemical staining (D), whereas anti-574G was adsorbed by Pep4 rather than Pep3 (E). Error bars:
mean7SD (n¼ 6). (F) Unchallenged subcon£uent cells (N), and subcon£uent cells challenged with 1mM CaCl2 (Ca) were cultured for 48 h, and prepared
for a western blot using anti-574G as described in Materials and Methods. Lines with numbers at the left indicate molecular markers (kDa).’, Anti-574G
bound to 33 kDa protein. (G) Unchallenged subcon£uent cells (N), and subcon£uent cells challenged with 1 mM CaCl2 (Ca) were cultured for 48 h, and
prepared for immunoprecipitation analysis using anti-94G as described in Materials and Methods. Lines with numbers at the left indicate molecular markers
(kDa).’, Anti-94G bound to 67 kDa protein. Heavy chain of anti-94G and other protein corresponding to anti-94G are indicated with an asterisk.
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by anti-574G. The cells swelled, resulting in modulation of the
morphology of the epidermis equivalent (Fig 5D,H).
DISCUSSION
Cleavage site-directed antibodies and their speci¢cities The
TGase1 protein is known to be very unstable, and is thus di⁄cult
to purify in quantity as an immunogen for the preparation of
antibodies. To detect proteolytically processed TGase1 proteins in
human epidermis, we therefore employed synthetic peptides that
mimic the cleavage sites of TGase1 as immunogens, and used
them to establish hybridomas producing TGase1-speci¢c
monoclonal antibodies (Figs 1 and 2A).
The binding speci¢cities of these monoclonal antibodies
against immunogen peptide are obvious from enzyme-linked
immunosorbent assay (Fig 2B,C). In addition, these antibodies
bind to cellular components of proliferating and/or di¡erenti-
ating keratinocytes in immuno£uorescence analyses (Figs 3^5).
The bindings of which were much reduced by the prior
incubation of the antibodies with the corresponding
immunogen peptides (Fig 2D,E). Moreover, western bolt
analysis for anti-574G and immunoprecipitation analysis for 94G
gave unique protein bands of 33 kDa and 67 kDa in molecular
weight, respectively (Fig 2F,G). These values are consistent
with those reported previously (Kim et al, 1995a). Therefore, we
conclude that the monoclonal antibodies established in this
Figure 3. Immuno£uorescence analysis of normal human skin. Fro-
zen sections of normal human skin were incubated with anti-574G (A) or
anti-94G (B), and visualized using FITC (green) as described in Materials
and Methods. Nuclei were stained with propidium iodide (red). Scale
bar¼ 50 mm. SC, stratum corneum; G, granular layers; SP, spinous layers;
BL, basal layers.
Figure 4. Immuno£uorescence analysis of monolayer cultured cells.
Normal human epidermal keratinocytes were seeded and grown in 0.3
mM calcium. Cells 1 d after the seeding (A,E), con£uent cells (B,F), cells
postcon£uently cultured for 48 h (C,G), and cells challenged with 1 mM
CaCl2 at subcon£uent and cultured for 48 h (D,H) were stained with
anti-574G (A^D) or anti-94G (E^H), and visualized using FITC (green) as
described in Materials and Methods. Nuclei were stained with propidium io-
dide (red). Scale bar¼ 50 mm.
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work bind speci¢cally to nativeTGase1-derived fragments.We do
not know why anti-94G could not bind to 67 kDa protein in
western blot analysis. It may be possible that treatment with the
SDS sample bu¡er and/or polyvinylidene £uoride membrane
attachment change the immunologic property of the protein.
Cleavage occurs in the basal layer cells of human
epidermis As shown in this study, both anti-94G and anti-
574G detected the TGase1 fragments early in the terminal
di¡erentiation of keratinocytes in the basal layer, as well as in
the whole human epidermis (Fig 3A,B). Furthermore, the
results of our in situ TGase assays on normal human skin
suggested that 94G fragment detected in the basal layer
keratinocytes already have enzymatic activity (Fig 6B).
It has been thought that TGase1 protein is expressed mainly in
the granular layer and plays a part in construction of the CE;
however, considering some previous reports that suggest TGase1
protein exists not only in granular layer but also in suprabasal and
spinous layers (Kim et al, 1995b), the subcellular localization and
function of TGase1 need to be re-evaluated. Recently,TGase1was
shown to be concentrated at E-cadherin-based adherence
junctions in mouse liver, suggesting that the TGase1 cross-
linking activity is important for the maintenance of the
structural integrity of simple epithelial cells (Hiiragi et al, 1999).
This report supports the idea that the TGase1 cross-linking
activity is not only used in the formation of CE in the granular
layer, but also in some other physiologic function, especially in
basal and spinous layer cells.
Cleavage at Glycine 574 precedes the cleavage at Glycine
94 On monolayer-cultured cells, 574G fragments were detected
in highly proliferative cells (Fig 4A) as well as in di¡erentiating
cells (Fig 4C,D), whereas 94G fragments were con¢ned to
di¡erentiating cells (Fig 4G,H). These results suggest that the
cleavage at Glycine 574 takes place earlier than that at Glycine
94, even in low concentration of Ca2þ in the medium,
implying that two kinds of proteases may be involved in the
cleavage of TGase1, or at least, that two cleavage events are
controlled di¡erently by a single protease. Although calpain, a
Ca2þ dependent intracellular protease, is a candidate of these
proteases (Garach-Jehoshua et al, 1998; Kim and Bae, 1998), the
e¡ect of various protease inhibitors and biochemical reagents to
Figure 5. Immuno£uorescence analysis
of three-dimensional skin equivalents.
LSE were cultured for 4 d without (A,E)
or with 5107 M 1-a-25-dihydroxycho-
lecalciferol (B,F) or 510^7 M RA (C,G).
Others were exposed to 25 mJ per cm2 ul-
traviolet B radiation from the air phase
every 4 d (D,H).The LSE were stained with
anti-574G (A^D) or anti-94G (E^H) and
visualized using FITC as described in Mate-
rials and Methods. Scale bar¼ 50 mm.
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regulate subtle changes in the intracellular Ca2þ concentration
(e.g., Ca2þ ionophores) may provide us with additional infor-
mation on proteolytic activation of TGase1.
Fate of 94G and 574G fragments In this study, the 94G
fragment was mainly detected along the periphery of
keratinocytes on immunohistochemical analysis (Figs 3B and 4).
These results imply that the 94G fragment is localized at the
plasma membrane. Consistent with this result, some previous
reports describe that the binding to membranes directs activity
of TGase1 (Steinert et al, 1996b; Nemes et al, 1999a, 2000). An
interesting question arising is what makes the 94G fragment
remain at the plasma membrane despite of the amino-terminal
region for membrane anchoring. In the basement membrane,
94G fragments were not detected (Fig 3B). The acceptor of 94G
fragment might be de¢cient in the plasma membrane adjacent to
basement membrane.
In contrast to the 94G fragment, the 574G fragment, which has
no enzymatic activity, is localized to the cytosolic portion of the
epidermis. Furthermore, the 574G fragment accumulates in the
stratum corneum, where the 94G fragment is not detected
(Fig 3A). This can be explained in that the 574G fragment is
stably maintained throughout the course of cell di¡erentiation,
independently to the 94G fragment. Therefore, the 574G
fragment may have another function in the process of normal
epidermis biogenesis, in addition to the previously hypothesized
role in removing the hindrance of catalytic core domain of its
own precursor formation (Candi et al, 1998), and in increasing
the activity of 94G fragment when they associate together (Kim
et al, 1995a).
A novel approach to detect the function of TGase1 in
various conditions We were successful in detecting TGase1
fragments in LSE as well. This in vitro system enabled us
to detect possible changes in epidermis of TGase1 processing
and subcellular localization of the fragments after various
treatments. Treatment with VD, a possible activator of TGase1
in cultured keratinocytes (Claus et al, 2000), RA, an inhibitor
of TGase1 activity in cultured keratinocytes (Fisher and
Voorhees, 1996), or ultraviolet B irradiation modulates
generation of the TGase1 fragment and/or localization of the
fragments. Furthermore, the morphology of terminally
di¡erentiated keratinocytes were strongly a¡ected when the
localization of TGase1 fragments were disturbed, although we
do not know yet whether these two events are related to each
other (Fig 5).
RA is known as one of the bioactive reagents that causes
complex phenomenon to keratinocyte. Saunders et al (1993)
reported that TGase1 mRNA levels are downregulated in RA-
treated cultured cells, whereas the most striking e¡ects of RA
treatment observed in our experiments were the disturbance of
subcellular localization of the 94G fragment, although
expression levels of TGase1 mRNA could not determined. In
our opinion, from this result, the altered biogenesis of epidermis
by treatment with RA may be caused at least in part by abnormal
subcellular localization of the active TGase1 fragment. As such,
our new antibodies will be useful tools for investigations about
proteolysis and/or localization of cellular TGase1 proteins in
various conditions.
In conclusion, we have established mouse hybridomas that
produce cleavage site-speci¢c antibodies against human TGase1
fragments. The antibodies allow us to dissect the mechanism by
whichTGase1 is activated and provide us with novel insights into
the biogenesis of epidermis.
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Figure 6. In situ TGase assays of normal human skin. 5-BAP incor-
poration with 5 mMCaCl2 (A,B) or with 5 mM ethylenediamine tetraacetic
acid (C) in normal human skin was visualized usingTRITC as described in
Materials and Methods. Positions of basement membranes are shown by dotted
lines (A,C). (B) Expansion chart of suprabasal layer. Scale bar¼ 50 m.
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